Gilles Edan is an expert in Neurology at Centre Hospitalier Universitaire de Rennes (France). As of October 2026, ScienceLeadR ranks Gilles Edan in the top 1% of experts worldwide for Multiple Sclerosis and Autoimmune Diseases. Gilles Edan has authored 455 publications, the most recent in 2026, and is an investigator in 32 clinical trials. SLR score: 1,436 (community average: 125). How the SLR is computed.

LeadR Profile

1 436 ScienceLeadR Reputation 1436
Network Map

Neurology

Subspecialties: Immunology - Informatics - Internal Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1989 - 2026

Source: PubMed

Centre Hospitalier Universitaire de Rennes

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 455

Citations

Citations: 42 150 1st author: 26 Last author: 65 Unique author: 19


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Anti-CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non-Active Multiple Sclerosis.
PMID 42596034 — sclerosis, multiple sclerosis, aged, therapeutics, nervous system diseases, infections
Ann Clin Transl Neurol20260
A multi-outcome prognostic score for therapeutic responses in multiple sclerosis.
PMID 42481360 — registries, sclerosis, multiple sclerosis, brain, multiple chronic conditions, therapeutics, wounds and injuries, neurology
Rev Neurol (Paris)20260
Global overview of multiple sclerosis care units: an international cross-sectional survey.
PMID 42318246 — sclerosis, multiple sclerosis, cross-sectional studies, classification, therapeutics, benchmarking, workforce
Front Neurol20261
Performances of experts and automated methods on new multiple sclerosis lesions detection: insights from the MSSeg2 challenge.
PMID 42168373 — sclerosis, multiple sclerosis, wounds and injuries
Sci Rep20260
PRIMUS: a precision medicine platform reusing clinical trials and registry data to support treatment selection in multiple sclerosis.
PMID 42131074 — registries, sclerosis, multiple sclerosis, mothers, precision medicine, therapeutics, neurologists
JAMIA Open20260

Clinical Studies 32

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5 Study Director: 2 Sub-Investigator: 1

By phase:

Phase 3 16
N/A 9
Phase 2 3
Phase 4 3
Phase 1 1

By status:

Completed 22
Unknown 4
Active not recruiting 2
Recruiting 2
Terminated 2

By type:

Interventional 25
Observational 7

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 2
multicentric5to9 4
multicentricup10 21

Main Topics

Cohort/Consortium Investigators 10

LeadR Networks

Main global connection map